PRIME Trademark

Trademark Overview

On Wednesday, April 1, 2020, a trademark application was filed for PRIME with the United States Patent and Trademark Office. The USPTO has given the PRIME trademark a serial number of 88856485. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Repertoire Immune Medicines, Inc.. The PRIME trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and therapeutic vaccines, namely, cellular preparations, T-cell preparations and DC (dendritic cell) for the treatment of cancer, immune system related diseases, and infectious disease
prime

General Information

Serial Number88856485
Word MarkPRIME
Filing DateWednesday, April 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and Servicespharmaceutical preparations and therapeutic vaccines, namely, cellular preparations, T-cell preparations and DC (dendritic cell) for the treatment of cancer, immune system related diseases, and infectious disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRepertoire Immune Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRepertoire Immune Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU EXTENSION 2 GRANTED
Monday, August 15, 2022SOU EXTENSION 2 FILED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 1 GRANTED
Monday, February 14, 2022SOU EXTENSION 1 FILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 17, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, July 4, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, March 22, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 28, 2020NON-FINAL ACTION E-MAILED
Sunday, June 28, 2020NON-FINAL ACTION WRITTEN
Monday, June 22, 2020ASSIGNED TO EXAMINER
Wednesday, April 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

prime preparations cell system immune related diseases disease infectious cancer dendritic